Retia Medical

Retia Medical is a digital health company based in Valhalla, New York, focused on advanced hemodynamic monitoring solutions. The company specializes in technologies that enhance patient care for high-risk surgical and critically ill patients. Its flagship product, the Argos Cardiac Output Monitor, utilizes a proprietary Multi-Beat Analysis algorithm to provide accurate and reliable hemodynamic measurements by analyzing multiple heartbeats. This innovation supports clinicians in monitoring cardiac output and vital parameters, improving patient safety during surgeries and in intensive care units. Retia Medical offers advanced monitoring tools that integrate into clinical workflows, promoting data-driven care for better patient outcomes. The company has established strategic partnerships, including a distribution agreement with Medtronic and collaborations with institutions like Temple University. Founded by CEO Marc Zemel, Retia Medical has a dedicated team with expertise in medical device innovation. The company has successfully raised $15 million in Series B funding to further develop its technology and accelerate commercialization.

• Employees 16
• Founded 2012
• Annual Revenue $7100000
• Total Funding $22000000